Skip to Content

Jerrold Blair Leikin, M.D.

Jerrold Blair Leikin, M.D.

Jerrold Blair Leikin, M.D.

Medical Toxicology, Internal Medicine, Emergency Medicine
  • Locations
    Locations
    A

    NorthShore Medical Group

    2150 Pfingsten Rd.
    Suite 3000
    Glenview, IL 60026
    847.657.1700 847.657.1711 fax Get Directions This location is wheelchair accessible.
  • Publications
    Publications
    • Caring for the transgender adolescent and young adult: Current concepts of an evolving process in the 21st century.

      Disease-a-month : DM 2019 Jul 26

      Authors: Temple LM
      Abstract
      Tetrahydrocannabinol (THC) is a psychoactive cannabinoid that has been used to treat various conditions. However, due to various adverse effects, its widespread promotion and use has been controversial. It is this aspect (encouraged by various state legislatures) that forms the basis for an edited debate between an Integrative Family Medicine physician and a Medical Toxicologist.
      Pro/Con debate with literature review and commentary.
      Medical THC is beneficial for various conditions (especially pain relief). However the dosing, titration and delivery system has of yet to be precisely defined. There is a paucity of studies focusing on cannabidiol (CBD) efficacy without THC, which further complicates medical cannabis clinical studies. Cannabis toxicity tends to be cumulative, which makes it more difficult to identify at the bedside.
      There is conflicting data regarding the efficacy and toxicity of medical use of THC.
      PMID: 31358290 [PubMed - as supplied by publisher]
    • Gastroesophageal reflux disease (GERD).

      Disease-a-month : DM 2019 Feb 19

      Authors: Leikin JB
      Abstract
      We describe the financial impact following the implementation of this unique specialty taxonomy code after October 1, 2017 on an established private medical toxicology practice.
      Clinical financial data over a 1-year period (October 2016 through September 2017) prior to medical toxicology specialty CMS code implementation was compared to financial data (October 2017 through September, 2018) following implementation. The encounters were billed by current procedural terminology (CPT) codes through the same biller during these time periods. Initial claim denial data were tracked throughout the appeals process.
      Overall, our initial denial rate decreased by 1.2% (with Medicare denials decreasing by 1.6% - excluding eligibility denials), resulting in a corresponding increase in a clean claim rate of 1.2%. This saved our practice $5477, between the 2 fiscal years.
      Medical toxicology specialty code implementation had an improved effect on our reimbursement denial rate to our practice.
      PMID: 30795847 [PubMed - as supplied by publisher]
    • Traumatic brain injury.

      Disease-a-month : DM 2019 Feb 16

      Authors:
      Abstract
      PMID: 30782414 [PubMed - as supplied by publisher]
  • In the News
    In the News

    May 2019

    Mar 2017

    Jul 2016

    Jun 2015

    May 2015

  • Social Media